CONTACT US
phone
+36 1 249 5029
"
Many people think they are happiest when they are resting or relaxing. However, they are more likely to report experiencing the greatest happiness when they are immersed in an activity or fully committed to overcoming a challenge.
Mihály
Csíkszentmihályi
Research Flow, an agency specializing in data analysis, market research, data visualization, biostatistics, and non-invasive research, was founded in 2015. We focus primarily on the healthcare sector, with a specialization in the prescription drug market.
Our success centers around our supportive and collaborative team, which brings together expertise from various fields to ensure accurate results. By combining our professional knowledge in healthcare research, statistics, data analysis, database building, and health sciences, we work with a mix of established research tools and innovative analyses.
We complement each other in terms of professional background, experience, and research methods, which makes us experts across the entire healthcare spectrum.
We believe it is important to approach every task individually and to extract results from the most appropriate data and information sources.
For us, it is essential to work as a trusted partner, thinking together with our clients. We listen to our partners, even involving them in the planning process, ensuring that the optimal combination of research methods provides well-supported answers.
Designing effective pharmaceutical and healthcare market research tools requires in-depth industry knowledge, whether it’s about prescribing habits, patient journey or group studies, new product launches, or other strategic questions and complex market analyses.
The findings of our research shed light on problems and uncover opportunities, helping guide strategic decisions. By approaching and examining issues thoroughly from multiple angles, we arrive at conclusions that lead to better outcomes.
Conducting effective pharmaceutical and healthcare market research requires extensive and comprehensive relationships. We maintain connections with healthcare professionals and institutions, pharmacies, regulatory authorities, advocacy groups, medical device manufacturers, and pharmaceutical companies. This enables us to design research that delivers results effectively applicable to product, marketing, market access, sales, or strategic development.
In our research, we have engaged about 7,000 doctors and healthcare professionals from 23 different fields.
We have analyzed prescription data for approximately 7 million patients in 32 different markets.
During our training sessions, we have helped over 620 pharmaceutical professionals better understand the biostatistical aspects of scientific publications.
We have educated approximately 3,600 specialists from 19 fields on how to critically read the methodological and statistical aspects of scientific articles, potentially influencing the treatment of 400,000 patients with evidence-based medicine.
Research Flow conducts descriptive and inferential statistical analysis and data mining of NEAK, direct hospital, and other (digital, corporate) databases. Our approach is business-focused, with products and services primarily designed to answer marketing, sales, and market access questions, but we also conduct RWE (Real World Evidence) scientific research based on database investigations.
In addition to our standard, uniform products, we also create custom-tailored analyses. Our basic principle is cost-efficiency, so we strive to extract the most value, both in terms of results and usability, from each data table. We have a deep understanding of Hungarian healthcare databases, allowing us to know the depth of questions they can answer.
Our market research and fieldwork business unit conducts classical qualitative (surveys) and quantitative (focus groups, in-depth interviews) market research, as well as applying unique methodologies (Delphi consensus) and non-interventional studies.
As an agency specializing in pharmaceutical research, we have extensive experience across almost all therapeutic areas, and we are well acquainted with the healthcare system. Our research is grounded in practical realities: how therapies and funding protocols are applied in medical practices.
Our goal is to provide realistic, objective, and transparent results, supported by our panel of more than 6,000 specialists and general practitioners.
We are well-versed in compliance, legal, and pharmacovigilance aspects of research, which we strictly observe and follow.
To convey marketing and sales messages, there is often a need for channels that complement personal visits, as well as content that can be effectively delivered through these channels to the target audience. Our Data-storytelling business unit translates messages into easy-to-understand and emotionally engaging visuals, infographics, and videos. Data storytelling is a key part of the overall Research Flow solution, supporting the entire marketing mix.
Our projects are handled by a highly skilled and creative team that sensitively crafts visually appealing materials with elements most effective for the target audience.
Whether the visualization is for scientific (medical education), educational (patient education), or internal purposes (campaign presentations), our final products are marked by creativity, elegance, and a distinctive voice unique to the commissioning company.
Within the healthcare sector, most of our projects are focused on data analysis and comprehensive research tasks related to prescription products. We treat every research project as unique, applying solutions tailored to the specific problem. At the same time, we also have many innovative, ready-to-adapt products that quickly provide reliable answers to our partners' questions.
In addition to traditional qualitative and quantitative market research techniques, we also use innovative tools that allow us to holistically examine questions such as the following:
What do we offer to our business partners?
When processing and presenting research results, our primary goal is to provide well-supported, easily actionable insights and conclusions to our clients, with expert analysis and practical recommendations, along with an executive summary. We place great emphasis on presenting our results clearly, concisely, and in an understandable way, avoiding data analysis and market research jargon.
We also consider it important to present results visually whenever possible.
Our in-house data visualization team helps bring the results to life: we supplement presentations with infographics, info-videos, and animations as needed, tailored to the client and target audience.
Infographic summaries and animations help disseminate research findings more broadly within the organization, and they can also be used for training purposes. Below are a few examples. (This is where the linked videos should be inserted.)
Request a free consultation, which does not obligate you in any way but may help in your decision-making process.
Jánosi, A., Ferenci, T., Bársony, G., Szabóné Póth, A., Vajer, P., & Andreka, P. (2022). Practices of Antiplatelet Therapy in Acute Myocardial Infarction. Orvosi Hetilap, 163, 743-749. doi: 10.1556/650.2022.32453
Karancsi, Z., Mazzag, B., Bársony, G., Szántó, M., Jerzsele, Á. (2024). Prevention and Treatment of Heartworm Disease in Veterinary Practices in Hungary. Magyar Állatorvosok Lapja, 2024. 01. 22-35. doi:10.56385/magyallorv.2024.01.23-35
Várkonyi, T., Balogh, Z., Brasnyó, P., Mazzag, B. (2023). Hungarian Perspectives and Practices in Treating Type 2 Diabetes: Delphi Consensus. Diabetologia Hungarica, 2023; 31(2): 123–138. doi:10.24121/dh.2023.11
Vojnisek, Zs., Bársony, G., Mazzag, B. (2024). Changes in Functional Gastrointestinal Symptoms in Infancy Using Adequate Formula Feeding. Táplálkozástudomány, XXIII. Évfolyam 1. szám, 290-293 (in press).
Szekeres, Gy., Rozsa, S., Dome, P., Barsony, G., Gonda, X. (2021). A Real-World, Prospective, Multicenter, Single-Arm Observational Study of Duloxetine in Patients With Major Depressive Disorder or Generalized Anxiety Disorder. Front. Psychiatry, 17 June 2021 Sec. Mood Disorders Volume 12 – 2021. doi: 10.3389/fpsyt.2021.689143
Lengyel, Cs., Mazzag, B. (2024). DELPHI CONSENSUS 2022: Hungarian Diabetologists’ Views on T2DM Insulin Treatment (in press).
Bajnok, L., Bársony, G. (2018). Statin Therapy After Acute Coronary Syndrome. Pécsi Data. Hungarian Atherosclerosis Society XXII. Congress. October 11-13, 2018.
phone
+36 1 249 5029
We currently have no open positions..
Dear Doctor,
Research Flow Ltd. conducts research in the healthcare sector on behalf of pharmaceutical companies. We would like to invite you to participate in our research studies and help us gather diverse opinions about companies, products, and active ingredients present in the healthcare market by providing your valuable responses. By filling out the following questionnaire, you agree that we may contact you for research participation through one of the provided contact details. If you are selected for one of our studies, we will enter into a framework agreement with you, which will provide a legal framework for participation in any subsequent studies.
Participation in our studies is always compensated, and the payment of honorarium is contingent upon the establishment of a contractual relationship. The data provided here will be used internally for the purpose of contacting you only. We do not share this data with third parties. The provided data will be retained until the signing of a framework agreement, or for a maximum of 3 months. The sole purpose of data management is to facilitate contact related to our market research; no other use of the data will be made. You can find our additional data management policies at the bottom of our website.